<DOC>
	<DOCNO>NCT02365246</DOCNO>
	<brief_summary>Removal IgE adsorption IgE specially design column apheresis blood potential improve severity atopic dermatitis . In study investigator treat patient severe form Atopic dermatitis respond much side effect systemic imunosuppressive treatment modality .</brief_summary>
	<brief_title>Treatment AD With IgE Specific Immunoadsorption ( IGEIAAD )</brief_title>
	<detailed_description>Patients treat immunoadsorption 4 consecutive day week 1 three consecutive day week 5 week 9 . The clinical improvement histological serological test evaluate .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>Inclusion criterion 1 . Adults ( &gt; 18 year ) severe atopic dermatitis ( objective SCORAD &gt; 40 ) 2. Who 's AD persistent stable since 1 year 3. Who sign informed consent 4. Who pregnant plan become pregnant , immunoadsorption treatment 5. Who treat recent past phototherapy immunosuppressive therapy ( one : cyclosporin A , methotrexate , azathioprine , mycophenolate , systemic corticosteroid ) therapy sufficiently helpful , unacceptable side effect contraindicate 1 . Patients give informed consent . 2 . Patients mild moderate AD . 3 . Patients severe AD improving , tolerate , standard therapy ( include phototherapy , short period corticosteroid , mention immunosuppressive therapy ) contraindication therapies 4 . Pregnant woman female patient willing become pregnant planned period treatment immediately . 5 . Having contraindication immunoadsorption : Patients know allergy material use immunoadsorption . Severe cardiovascular disease . Severe bleed anticoagulation . Treated ACEinhibitors . Patients young than18 year . 6 . Having malignant disease remission</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>atopic dermatitis</keyword>
	<keyword>immunoadsorption</keyword>
</DOC>